The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: Evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy
Open accessAbstract
Objective: To evaluate the proposed relationship between persistent reduction of serum urate into the subsaturating range and reduction in the frequency of acute gouty attacks. Methods: We retrospectively examined data derived from 267 patients who had experienced at least 1 gouty attack before their first visit to our clinic. Serum urate concentration, history of recurrent gouty attacks, and information about antihyperuricemic drug use were collected on each visit for up to 3 years from the first visit of each patient. Data derived from visits >1 year after study entry were subjected to statistical analysis. Results: When adjusted for baseline serum urate level and the number of gouty attacks prior to study entry, reduction of followup serum urate concentration and antihyperuricemic drug use were each significantly associated with a reduced risk of gouty attacks (odds ratio [OR] 0.42, 95% confidence interval [95% CI] 0.31–0.57; OR 0.22, 95% CI 0.10–0.47, respectively). Conclusion: The data indicate that reduction of serum urate concentrations to 6 mg/dl or lower will eventually result in a reduced frequency or prevention of future gouty attacks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preliminary criteria for the classification of the acute arthritis of primary gout
Wallace, S. L., Robinson, H., Masi, A. T., Decker, J. L., Mccarty, D. J., & Yü, T. (1977) · Arthritis & Rheumatism · doi:10.1002/art.1780200320 · Cited by 1,432
Emmerson, B. T. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602153340707 · Cited by 516
Perez-Ruiz, F., Alonso-Ruiz, A., Calabozo, M., Herrero-Beites, A., García-Erauskin, G., & Ruiz-Lucea, E. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.9.545 · Cited by 257
Li‐Yu, J., Clayburne, G. M., Sieck, M. S., Beutler, A. M., Rull, M., Eisner, E. V., & Schumacher, H. R. (2001) · PubMed · Cited by 193
Yamanaka, H., Togashi, R., Hakoda, M., Terai, C., Kashiwazaki, S., Dan, T., & Kamatani, N. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5381-6_3 · Cited by 103
Self-citationArthritis and Allied Conditions.
(1942) · Archives of Internal Medicine · doi:10.1001/archinte.1942.00200200165010 · Cited by 96
Gout: can management be improved?
Schlesinger, N., & Schumacher, H. R. (2001) · Current Opinion in Rheumatology · doi:10.1097/00002281-200105000-00016 · Cited by 63
Cameron, J. S., & Simmonds, H. A. (1987) · BMJ · doi:10.1136/bmj.294.6586.1504 · Cited by 63
Matzkies, F. K. (1978) · PubMed · Cited by 9
Cited by
Khanna, D., Fitzgerald, J. D., Khanna, P. P., Bae, S., Singh, M. K., Neogi, T., Pillinger, M. H., Merill, J., Lee, S., Prakash, S., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21772 · Cited by 1,536
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
Becker, M. A., Schumacher, H. R., Wortmann, R. L., MacDonald, P. A., Eustace, D., Palo, W. A., Streit, J., & Joseph-Ridge, N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050373 · Cited by 1,357
2020 American College of Rheumatology Guideline for the Management of Gout
FitzGerald, J. D., Dalbeth, N., Mikuls, T., Brignardello‐Petersen, R., Guyatt, G., Abeles, A. M., Gelber, A. C., Harrold, L. R., Khanna, D., King, C., et al. (2020) · Arthritis Care & Research · doi:10.1002/acr.24180 · Cited by 983
Choi, H. K., Mount, D. B., & Reginato, A. M. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-7-200510040-00009 · Cited by 942
2020 American College of Rheumatology Guideline for the Management of Gout
FitzGerald, J. D., Dalbeth, N., Mikuls, T., Brignardello‐Petersen, R., Guyatt, G., Abeles, A. M., Gelber, A. C., Harrold, L. R., Khanna, D., King, C., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41247 · Cited by 810
Khanna, D., Khanna, P. P., Fitzgerald, J. D., Singh, M. K., Bae, S., Neogi, T., Pillinger, M. H., Merill, J., Lee, S., Prakash, S., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21773 · Cited by 728
Schumacher, H. R., Becker, M. A., Wortmann, R. L., MacDonald, P. A., Hunt, B., Streit, J., Lademacher, C., & Joseph‐Ridge, N. (2008) · Arthritis Care & Research · doi:10.1002/art.24209 · Cited by 638
Jordan, K. M., Cameron, J. S., Snaith, M., Zhang, W., Doherty, M., Seckl, J., Hingorani, A., Jaques, R., & Nuki, G. (2007) · Rheumatology · doi:10.1093/rheumatology/kem056a · Cited by 552
Becker, M. A., Schumacher, H. R., Espinoza, L. R., Wells, A. F., MacDonald, P., Lloyd, E., & Lademacher, C. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2978 · Cited by 529
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005
Annemans, L., Spaepen, E., Gaskin, M., Bonnemaire, M., Malier, V, Gilbert, T., & Nuki, G. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.076232 · Cited by 495
Ganson, N. J., Kelly, S. J., Scarlett, E., Sundy, J. S., & Hershfield, M. S. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1861 · Cited by 350
Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase
Takano, Y., Hase-Aoki, K., Horiuchi, H., Zhao, L., Kasahara, Y., Kondo, S., & Becker, M. A. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.10.031 · Cited by 334
The Crystallization of Monosodium Urate
Martillo, M. A., Nazzal, L., & Crittenden, D. B. (2014) · Current Rheumatology Reports · doi:10.1007/s11926-013-0400-9 · Cited by 330
The British Society for Rheumatology Guideline for the Management of Gout
Hui, M., Carr, A., Cameron, S., Davenport, G., Doherty, M., Forrester, H., Jenkins, W., Jordan, K. M., Mallen, C. D., McDonald, T. M., et al. (2017) · Rheumatology · doi:10.1093/rheumatology/kex156 · Cited by 316
Japanese Guideline for the Management of Hyperuricemia and Gout: Second Edition
Yamanaka, H. (2011) · Nucleosides, Nucleotides and Nucleic Acids · doi:10.1080/15257770.2011.596496 · Cited by 306
Self-citationRisk factors for gout and prevention: a systematic review of the literature
Singh, J. A., Reddy, S. G., & Kundukulam, J. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283438e13 · Cited by 298
Stamp, L. K., Taylor, W. J., Jones, P. B., Dockerty, J. L., Drake, J., Frampton, C., & Dalbeth, N. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34488 · Cited by 296
Sarawate, C. A., Brewer, K. K., Yang, W., Patel, P. A., Schumacher, H. R., Saag, K. G., & Bakst, A. W. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.7.925 · Cited by 292
BECKER, M. A., SCHUMACHER, H. R., MacDONALD, P. A., LLOYD, E., & LADEMACHER, C. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.080814 · Cited by 269
Uric Acid as a Target of Therapy in CKD
Jalal, D. I., Chonchol, M., Chen, W., & Targher, G. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.07.021 · Cited by 268
Becker, M. A., Schumacher, H. R., Wortmann, R. L., MacDonald, P. A., Palo, W. A., Eustace, D., Vernillet, L., & Joseph‐Ridge, N. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20935 · Cited by 266
Sivera, F., Andrés, M., Carmona, L., Kydd, A. S. R., Moi, J., Seth, R., Sriranganathan, M., van Durme, C., van Echteld, I., Vinik, O., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203325 · Cited by 262
Remembering the forgotten non-communicable diseases
Lopez, A. D., Williams, T. N., Levin, A., Tonelli, M., Singh, J. A., Burney, P. G., Rehm, J., Volkow, N. D., Koob, G., & Ferri, C. P. (2014) · BMC Medicine · doi:10.1186/s12916-014-0200-8 · Cited by 108
Arts, I. C., Coolen, E. J., Bours, M. J., Huyghebaert, N., Stuart, M. A. C., Bast, A., & Dagnelie, P. C. (2012) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-9-16 · Cited by 33
Metadata
- Authors
- Shoji, A., Yamanaka, H., & Kamatani, N.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2004-06-03
- Volume
- 51
- Issue
- 3
- Pages
- 321-325
- ISSN
- 0893-7524 (ISSN-L)
- 1529-0123
- OpenAlex
- W1534146221
- Cited by
- 438
- References
- 9
- FWCI
- 9.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.